Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 6/20 | 0.45 |
| ▸ | MMP9 | P14780 | 6/20 | 0.45 |
| ▸ | MMP8 | P22894 | 6/20 | 0.45 |
| ▸ | MMP12 | P39900 | 6/20 | 0.45 |
| ▸ | MMP13 | P45452 | 6/20 | 0.45 |
| ▸ | MMP14 | P50281 | 6/20 | 0.45 |
| ▸ | MMP16 | P51512 | 6/20 | 0.45 |
| ▸ | MMP3 | P08254 | 4/20 | 0.44 |
| ▸ | MMP1 | P03956 | 3/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alanine SCHEMBL11038489 | 0.91 | MMP2 (0.43) | MMP2MMP9MMP8MMP12MMP13 | |
| SCHEMBL9626817 | 0.86 | RECQL (0.47) | MMP2MMP9MMP8MMP12MMP13 | |
| SCHEMBL22652933 | 0.83 | GAA (0.48) | MMP2MMP9MMP8MMP12MMP13 | |
| SCHEMBL13908249 | 0.81 | MMP2 (0.53) | MMP2MMP9MMP8MMP12MMP13 | |
| SCHEMBL5331978 | 0.80 | HTR2A (0.51) | MMP2MMP9MMP8MMP12MMP13 | |
| SCHEMBL8988719 | 0.79 | CA1 (0.59) | MMP2MMP9MMP8MMP12MMP13 | |
| SCHEMBL11853033 | 0.76 | GAA (0.68) | GAAHSD11B1L3MBTL1HTTSMN1; SMN2 | |
| SCHEMBL31000980 | 0.76 | GAA (0.68) | GAAHSD11B1L3MBTL1HTTSMN1; SMN2 | |
| SCHEMBL9772295 | 0.76 | CNR2 (0.48) | MMP2MMP9MMP8MMP12MMP13 | |
| SCHEMBL3890776 | 0.76 | GAA (0.57) | RECQLGAAHSD11B1KMT2ACA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10307505-B2 | Wound dressings for the controlled release of therapeutic agents | KCI USA, INC. (US) | 2019-06-04 | — | — | US | claimed |
| US-20170333592-A1 | Wound Dressings For The Controlled Release Of Therapeutic Agents | SYSTAGENIX WOUND MANAGEMENT, LIMITED (GB) | 2017-11-23 | — | — | US | claimed |
| US-9687581-B2 | Wound dressings for the controlled release of therapeutic agents | KCI USA, INC. (US) | 2017-06-27 | — | — | US | claimed |
| US-20150098985-A1 | WOUND DRESSINGS FOR THE CONTROLLED RELEASE OF THERAPEUTIC | KCI USA, INC. | 2015-04-09 | — | — | US | claimed |
| US-8858987-B2 | Wound dressing for the controlled release of therapeutic agents | SYSTAGENIX WOUND MANAGEMENT (US), INC. (US) | 2014-10-14 | — | — | US | claimed |
| EP-1687039-B1 | WOUND DRESSINGS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS | ETHICON INC (US) | 2009-01-28 | — | — | EP | claimed |
| US-20070148214-A1 | Wound dressing for the controlled release of therapeutic agents | KCI USA, INC. | 2007-06-28 | — | — | US | claimed |
| EP-1687039-A1 | WOUND DRESSINGS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS | ETHICON, INC. (US) | 2006-08-09 | — | — | EP | claimed |
| WO-2005051441-A1 | WOUND DRESSINGS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS | ETHICON, INC. (US) | 2005-06-09 | — | — | WO | claimed |
| US-20200221753-A1 | TEXTURED INGESTIBLE PRODUCTS | EETBE INC (US) | 2020-07-16 | — | — | US | disclosed |
| US-10307505-B2 | Wound dressings for the controlled release of therapeutic agents | KCI USA, INC. (US) | 2019-06-04 | — | — | US | disclosed |
| US-20170333592-A1 | Wound Dressings For The Controlled Release Of Therapeutic Agents | SYSTAGENIX WOUND MANAGEMENT, LIMITED (GB) | 2017-11-23 | — | — | US | disclosed |
| US-20170196253-A1 | TEXTURED INGESTIBLE PRODUCTS | EETBE, INC. | 2017-07-13 | — | — | US | disclosed |
| US-9687581-B2 | Wound dressings for the controlled release of therapeutic agents | KCI USA, INC. (US) | 2017-06-27 | — | — | US | disclosed |
| WO-2005051441-A1 | WOUND DRESSINGS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS | ETHICON, INC. (US) | 2005-06-09 | — | — | WO | disclosed |
| US-20040166530-A1 | F-box proteins and genes | HARPER JEFFREY WADE (US) | 2004-08-26 | — | — | US | disclosed |
| WO-2004041179-A2 | SCAVENGER RECEPTOR B1 (CLA-1) TARGETING FOR THE TREATMENT OF INFECTION, SEPSIS AND INFLAMMATION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF HEALTH AND HUMAN SERVICES, NIH (US) | 2004-05-21 | — | — | WO | disclosed |
| US-6573094-B1 | Identification of components of E3 complex involved in ubiquitination of cell cycle regulator proteins, including a class of proteins that directly function in recognition of ubiquitination targets; use for drug discovery and assessment | BAYLOR COLLEGE OF MEDICINE | 2003-06-03 | — | — | US | disclosed |
| US-6232081-B1 | COMPLEXING WITH SLIMB PROTEIN | BAYLOR COLLEGE OF MEDICINE | 2001-05-15 | — | — | US | disclosed |
| US-5328844-A | Amino acid nutrients | UNIVERSITY OF COLORADO FOUNDATION, INC. (US) | 1994-07-12 | — | — | US | disclosed |